The estimated Net Worth of Paula J Swain is at least $6.77 Milhão dollars as of 1 September 2023. Ms. Swain owns over 8,449 units of Incyte stock worth over $4,894,469 and over the last 21 years she sold INCY stock worth over $550,283. In addition, she makes $1,327,560 as Executive Vice President - Human Resources at Incyte.
Paula has made over 44 trades of the Incyte stock since 2006, according to the Form 4 filled with the SEC. Most recently she sold 8,449 units of INCY stock worth $550,283 on 1 September 2023.
The largest trade she's ever made was exercising 216,967 units of Incyte stock on 13 February 2014 worth over $2,291,172. On average, Paula trades about 13,852 units every 71 days since 2004. As of 1 September 2023 she still owns at least 77,530 units of Incyte stock.
You can see the complete history of Ms. Swain stock trades at the bottom of the page.
Paula J. Swain is the Executive Vice President - Human Resources of Incyte Corporation. She has served as Executive Vice President, Human Resources since August 2002 and joined Incyte as Senior Vice President of Human Resources in January 2002. Ms. Swain served as Senior Vice President of Human Resources at Bristol-Myers Squibb Company from October 2001 to January 2002, after it acquired DuPont Pharmaceuticals Company. From July 1998 to October 2001, Ms. Swain was Senior Vice President of Human Resources at DuPont Pharmaceuticals. From October 1992 to July 1998, Ms. Swain held a variety of human resources positions of increasing responsibility at DuPont Pharmaceuticals. Ms. Swain received her B.A. in Psychology and Industrial Relations from Rockhurst University.
As the Executive Vice President - Human Resources of Incyte, the total compensation of Paula Swain at Incyte is $1,327,560. There are 7 executives at Incyte getting paid more, with Herve Hoppenot having the highest compensation of $15,151,200.
Paula Swain is 61, she's been the Executive Vice President - Human Resources of Incyte since 2002. There are 8 older and 17 younger executives at Incyte. The oldest executive at Incyte Corp. is Pamela M. Murphy, 70, who is the VP of Investor Relations & Corp. Communications.
Paula's mailing address filed with the SEC is 1801 AUGUSTINE CUT-OFF, , WILMINGTON, DE, 19803.
Over the last 21 years, insiders at Incyte have traded over $114,417,378 worth of Incyte stock and bought 24,211,970 units worth $713,884,116 . The most active insiders traders include Bros. Advisors Lp14159, L.P..., Bros. Advisors Lp667, L.P.B..., eBrothers Life Sciences Capi.... On average, Incyte executives and independent directors trade stock every 14 days with the average trade being worth of $4,355,654. The most recent stock trade was executed by Steven H Stein on 12 August 2024, trading 11,608 units of INCY stock currently worth $703,793.
incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. we have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. the incyte corporate headquarters is located in wilmington, delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders. for more information about incyte, please visit our corporate website at www.incyte.com.
Incyte executives and other stock owners filed with the SEC include: